https://www.selleckchem.com/pr....oducts/3-deazaadenos
RNA-seq revealed that CD133 deficiency dysregulated the p53, PI3K-Akt, AMPK, and Wnt signaling pathways. Alterations in these pathways have been implicated in tumor proliferation and apoptotic escape. Conclusions Our data imply that CD133 could be an additional target and used as a selective marker to sort and eliminate undifferentiated cells in reducing potential teratoma formation risk of hESCs in regenerative medicine.Background Mesenchymal stromal cell conditioned medium (MSC-CM) contains a cocktail of bioacti
Like
Comment
Share
